# US 2021/0009979 A1 · Subtilase variants and compositions comprising same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0009979 A1
- Document ID: US20210009979A1
- Status: Published application
- Kind: A1
- Application number: 17/040,207
- Filed: 2019-03-21
- Published: 2021-01-14
- Earliest claimed: 2018-03-23
- Assignees: Novozymes A/S
- Applicants: Novozymes A/S
- Inventors: Esben Peter Friis; Rolf Thomas Lenhard; Lars Lehmann Hylling Christensen; Carl Mikael Bauer
- Web page: https://patentgrep.com/patent/US20210009979A1

## CPC

- C12N 9/54: bacteria being Bacillus
- C11D 3/386: Preparations containing enzymes {, e.g. protease or amylase}
- C11D 3/38618: {Protease or amylase in liquid compositions only}
- C11D 3/38663: {Stabilised liquid enzyme compositions}
- C12Y 304/21062: Subtilisin (3.4.21.62)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C11D: DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C12Y: ENZYMES

## Abstract

The invention relates to subtilase variants and detergent compositions comprising the variants, as well as methods of producing the variants and methods for stabilizing a subtilase variant.

## Claims

### Claim 1

A subtilase variant, comprising mutations at three or more positions selected from the group consisting of 9, 63, 76, 88, 104, 107, 128, 131, 159, 204, 206, 209, 212, 215, 216, 261 and 262, wherein positions are numbered according to SEQ ID NO: 1, and wherein the variant has protease activity and a sequence identity to SEQ ID NO: 1 of at least 80% and less than 100%.

### Claim 2 (depends on 1)

The subtilase variant of claim 1, wherein the variant comprises mutations at three or more positions selected from the group consisting of:
(i) 209 in combination with two or more mutations at positions selected from 63, 215 and 217;
(ii) 104 and 128 in combination with at least one mutation at a position selected from 9, 63, 76, 107, 131, 159, 204, 206, 212, 215, 216 and 217;
(iii) 9 in combination with at least two mutations at positions selected from 76, 204 and 212;
(iv) 76 in combination with at least two mutations at positions selected from 9, 88, 159, 204, 206, 212, 216, 261 and 262;
(v) 206 in combination with at least two mutations at positions selected from 9, 76, 159, 204, 209, 212, 216, 217, 261 and 262; and
(vi) 204, 212 and 216, in combination with at least one mutation at a position selected from 9, 159 and 206.

### Claim 3 (depends on 1)

The subtilase variant of claim 1, wherein:
the mutation in position 9 is S9E or S9D,
the mutation in position 63 is S63G or S63A,
the mutation in position 76 is N76D or N76E,
the mutation in position 88 is A88V, A88I, A88L or A88M,
the mutation in position 104 is Y104V, Y104I, Y104L or Y104M,
the mutation in position 107 is I107L, I107V, I107M,
the mutation in position 128 is G128S, G128A or G128T,
the mutation in position 131 is G131* or G131P,
the mutation in position 159 is S159E or S159D,
the mutation in position 204 is S204D or S204E,
the mutation in position 206 is Q206L, Q206I, Q206V or Q206M,
the mutation in position 209 is L209W,
the mutation in position 212 is N212G, N212A or N212S,
the mutation in position 215 is G215A,
the mutation in position 216 is A216V, A216I, A216L or A216M,
the mutation in position 217 is Y217L, Y217I, Y217V or Y217M,
the mutation in position 261 is F261W, F261N or F261Y, and/or
the mutation in position 262 is Y262E or Y262D.

### Claim 4 (depends on 1)

The subtilase variant of claim 1, comprising three or more mutations selected from the group consisting of:
L209W in combination with two or more substitutions selected from S63G/A, G215A and Y217L/I/V/M;
(ii) Y104V/I/L/M and G128S/A/T in combination with at least one mutation selected from S9E/D, S63G/A, N76D/E, I107L/V/M, G131*, G131P, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S, G215A, A216V/I/L/M and Y217L/I/V/M;
(iii) S9E/D in combination with at least two substitutions selected from N76D/E, S204D/E and N212G/A/S;
(iv) N76D/E in combination with at least two substitutions selected from S9E/D, A88V/I/L/M, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S, A216V/I/L/M, F261W/N/Y and Y262E/D;
(v) Q206L/I/V/M in combination with at least two substitutions selected from S9E/D, N76D/E, S159E/D, S204D/E, L209W/N/Y, N212G/A/S, A216V/I/L/M, Y217L/I/V/M, F261W/N/Y and Y262E/D; and
(vi) S204D/E, N212G/A/S and A216V/I/L/M, in combination with at least one substitution selected from S9E/D, S159E/D and Q206L/I/V/M.

### Claim 5

A subtilase variant, comprising the substitution L209W and at least two substitutions selected from the group consisting of S63G/A, G215A and Y217L/I/V/M, wherein positions are numbered according to SEQ ID NO: 1, and wherein the variant has protease activity and a sequence identity to SEQ ID NO: 1 of at least 80% and less than 100%.

### Claim 6 (depends on 5)

The subtilase variant of claim 5, comprising the substitutions S63G, L209W, G215A and Y217L.

### Claim 7 (depends on 5)

The subtilase variant of claim 5, further comprising at least one mutation selected from the group consisting of S9E/D, N76D/E, Y104V/I/L/M, G128S/A/T, G131*, G131P, S204D/E, Q206L/I/V/M, A216V/I/L/M, F261W/N/Y and Y262E/D.

### Claim 8 (depends on 5)

The subtilase variant of claim 5, comprising one of the following sets of mutations:
S63G L209W G215A Y217L;
S9E S63G L209W G215A Y217L;
S63G N76D L209W G215A Y217L;
S63G S204D L209W G215A Y217L;
S63G Q206L L209W G215A A216V Y217L;
S63G Q206L L209W G215A Y217L;
S63G L209W G215A Y217L F261W Y262E;
S63G Y104V G128S G131* L209W G215A Y217L; or
S63G Y104V G128S G131P L209W G215A Y217L.

### Claim 9

A subtilase variant, comprising the substitutions Y104V/I/L/M+G128S/A/T, and (a) at least two mutations selected from the group consisting of S9E/D, N76D/E, I107L/V/M, G131*, G131P, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S and A216V/I/L/M, or (b) L209W and at least two substitutions selected from the group consisting of S63G/A, G215A and Y217L/I/V/M, wherein positions are numbered according to SEQ ID NO: 1, and wherein the variant has protease activity and a sequence identity to SEQ ID NO: 1 of at least 80% and less than 100%.

### Claim 10 (depends on 9)

The subtilase variant of claim 9, comprising one of the following sets of mutations:
N76D Y104V G128S G131* N212G;
N76D Y104V G128S G131P;
N76D Y104V G128S G131*;
Y104V I107L G128S G131* Q206L;
N76D Y104V G128S G131P N212G;
S63G Y104V G128S G131* L209W G215A Y217L;
Y104V G128S G131* Q206L A216V;
S63G Y104V G128S G131P L209W G215A Y217L;
Y104V G128S G131* Q206L;
Y104V G128S G131* S159E Q206L A216V;
Y104V G128S G131* S204D N212G;
Y104V G128S G131P S204D N212G;
Y104V G128S G131P Q206L A216V;
S9E Y104V G128S G131*;
Y104V G128S G131P Q206L;
Y104V G128S G131P S159E Q206L;
S9E Y104V G128S G131P; or
Y104V G128S G131P S159E Q206L A216V.

### Claim 11

A subtilase variant, comprising at least three mutations selected from the group consisting of S9E/D, N76D/E, A88V/I/L/M, S159E/D, S204D/E, Q206L/I/V/M, L209W, N212G/A/S, A216V/I/L/M, Y217L/I/V/M, F261W/N/T and Y262E/D, wherein positions are numbered according to SEQ ID NO: 1, and wherein the variant has protease activity and a sequence identity to SEQ ID NO: 1 of at least 80% and less than 100%.

### Claim 12 (depends on 11)

The subtilase variant of claim 11, comprising one of the following sets of mutations:
N76D S159E Q206L N212G A216V;
S204D Q206L N212G A216V;
Q206L N212G A216V;
S159E Q206L N212G A216V;
S9E S159E Q206L A216V;
N76D N212G F261W Y262E;
S204D Q206L N212G;
S9E S204D N212G;
N76D A88V S204D N212G;
Q206L F261W Y262E; or
Q206L L209W A216V Y217L.

### Claim 13 (depends on 1)

The subtilase variant of claim 1, wherein the variant has an increased storage stability in a detergent composition compared to the subtilase of SEQ ID NO: 1.

### Claim 14 (depends on 13)

The subtilase variant of claim 13, wherein the variant has an increased storage stability in a detergent composition compared to the subtilase of SEQ ID NO: 1 when measured for 24 hours as described in storage stability assay I in Example 2 herein, and/or as measured as described in storage stability assay II in Example 3 herein.

### Claim 15 (depends on 14)

The subtilase variant of claim 14, wherein the variant has an increased storage stability in a detergent composition compared to the subtilase of SEQ ID NO: 1 of at least 25% when measured for 24 hours as described in storage stability assay I in Example 3 herein, and/or as measured as described in storage stability assay II in Example 4 herein.

### Claim 16

A method for stabilizing a subtilase variant, the method comprising introducing into a parent subtilase having protease activity and at least 80% sequence identity to SEQ ID NO: 1 at least three mutations selected from:
L209W in combination with two or more substitutions selected from S63G/A, G215A and Y217L/I/V/M;
(ii) Y104V/I/L/M and G128S/A/T in combination with at least one mutation selected from S9E/D, S63G/A, N76D/E, I107L/V/M, G131*, G131P, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S, G215A, A216V/I/L/M and Y217L/I/V/M;
(iii) S9E/D in combination with at least two substitutions selected from N76D/E, S204D/E and N212G/A/S;
(iv) N76D/E in combination with at least two substitutions selected from S9E/D, A88V/I/L/M, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S, A216V/I/L/M, F261W/N/Y and Y262E/D;
(v) Q206L/I/V/M in combination with at least two substitutions selected from S9E/D, N76D/E, S159E/D, S204D/E, L209W/N/Y, N212G/A/S, A216V/I/L/M, Y217L/l/V/M, F261W/N/Y and Y262E/D; and
(vi) S204D/E, N212G/A/S and A216V/I/L/M, preferably in combination with at least one substitution selected from S9E/D, S159E/D and Q206L/I/V/M.

### Claim 17 (depends on 16)

The method of claim 16, wherein the stabilized subtilase variant has an increased storage stability in a detergent composition compared to the subtilase of SEQ ID NO: 1.

### Claim 18 (depends on 17)

The method of claim 17, wherein the variant has an increased storage stability in a detergent composition compared to the subtilase of SEQ ID NO: 1 when measured for 24 hours as described in storage stability assay I in Example 3 herein, and/or as measured as described in storage stability assay II in Example 4 herein.

### Claim 19 (depends on 18)

The method of claim 18, wherein the variant has an increased storage stability in a detergent composition compared to the subtilase of SEQ ID NO: 1 of at least 25% when measured for 24 hours as described in storage stability assay I in Example 3 herein, and/or as measured as described in storage stability assay II in Example 4 herein.

### Claim 20

A method for obtaining a subtilase variant, the method comprising (a) providing a host cell comprising a polynucleotide encoding a variant of a parent protease having three or more mutations, e.g. four or more mutations, compared to SEQ ID NO: 1, wherein the variant has protease activity and a sequence identity to SEQ ID NO: 1 of at least 80%, and wherein the mutations are selected from:
L209W in combination with two or more substitutions selected from S63G/A, G215A and Y217L/I/V/M;
(ii) Y104V/I/L/M and G128S/A/T in combination with at least one mutation selected from S9E/D, S63G/A, N76D/E, I107L/V/M, G131*, G131P, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S, G215A, A216V/I/L/M and Y217L/I/V/M;
(iii) S9E/D in combination with at least two substitutions selected from N76D/E, S204D/E and N212G/A/S;
(iv) N76D/E in combination with at least two substitutions selected from S9E/D, A88V/I/L/M, S159E/D, S204D/E, Q206L/I/V/M, N212G/A/S, A216V/I/L/M, F261W/N/Y and Y262E/D;
(v) Q206L/I/V/M in combination with at least two substitutions selected from S9E/D, N76D/E, S159E/D, S204D/E, L209W/N/Y, N212G/A/S, A216V/I/L/M, Y217L/I/V/M, F261W/N/Y and Y262E/D; and
(vi) S204D/E, N212G/A/S and A216V/I/L/M, preferably in combination with at least one substitution selected from S9E/D, S159E/D and Q206L/I/V/M;
(b) cultivating the host cell under conditions suitable for expression of the variant; and
(c) recovering the variant.

### Claim 21 (depends on 1)

A detergent composition comprising a subtilase variant according to claim 1 and at least one detergent component, and optionally further comprising at least one additional enzyme.

### Claim 22

(canceled)
